- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/603 - Salicylic acid; Derivatives thereof having further aromatic rings, e.g. diflunisal
Patent holdings for IPC class A61K 31/603
Total number of patents in this class: 58
10-year publication summary
|
6
|
3
|
8
|
6
|
9
|
6
|
2
|
2
|
7
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| SOM Innovation Biotech, S.L. | 13 |
5 |
| Biosuccess Biotech Co. Ltd. | 25 |
4 |
| Aurin Biotech Inc. | 14 |
3 |
| Sen-jam Pharmaceutical LLC | 13 |
3 |
| The Regents of the University of California | 19493 |
2 |
| Kao Corporation | 4903 |
2 |
| Alnylam Pharmaceuticals, Inc. | 1129 |
2 |
| Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 803 |
2 |
| University of Fukui | 78 |
2 |
| Vestlandets Innovasjonsselskap AS | 45 |
2 |
| Pfizer Inc. | 3371 |
1 |
| Purdue Research Foundation | 3471 |
1 |
| Allergan Pharmaceuticals International Limited | 243 |
1 |
| Alma Mater Studiorum - Universita di Bologna | 392 |
1 |
| Antibe Therapeutics Inc. | 21 |
1 |
| Board of Supervisors of Louisiana State University | 31 |
1 |
| Boyce Thompson Institute for Plant Research, Inc. | 30 |
1 |
| Brown University | 627 |
1 |
| China Pharmaceutical University | 270 |
1 |
| Chu de Bordeaux | 20 |
1 |
| Other owners | 21 |